{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:18:29Z","timestamp":1772525909192,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s11910-023-01310-1","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:02:44Z","timestamp":1697184164000},"page":"727-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["REM Behavior Disorder: Implications for PD Therapeutics"],"prefix":"10.1007","volume":"23","author":[{"given":"Jeanne S.","family":"Feuerstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Amara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"issue":"2","key":"1310_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","volume":"9","author":"CH Schenck","year":"1986","unstructured":"Schenck CH, et al. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9(2):293\u2013308.","journal-title":"Sleep."},{"issue":"8","key":"1310_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.sleep.2013.02.016","volume":"14","author":"CH Schenck","year":"2013","unstructured":"Schenck CH, et al. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med. 2013;14(8):795\u2013806.","journal-title":"Sleep Med."},{"issue":"1","key":"1310_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.sleep.2014.09.011","volume":"16","author":"IR McGrane","year":"2015","unstructured":"McGrane IR, et al. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. Sleep Med. 2015;16(1):19\u201326.","journal-title":"Sleep Med."},{"issue":"8","key":"1310_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","volume":"14","author":"CH Schenck","year":"2013","unstructured":"Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013;14(8):744\u20138.","journal-title":"Sleep Med."},{"issue":"12","key":"1310_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord."},{"issue":"3","key":"1310_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma RB, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744\u201359.","journal-title":"Brain."},{"key":"1310_CR7","doi-asserted-by":"publisher","unstructured":"Sasai-Sakuma T, et al. Prevalence and clinical characteristics of REM sleep behavior disorder in Japanese elderly people. Sleep. 2020;43(8):zsaa024. https:\/\/doi.org\/10.1093\/sleep\/zsaa024.","DOI":"10.1093\/sleep\/zsaa024"},{"issue":"8","key":"1310_CR8","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.5665\/sleep.2874","volume":"36","author":"SH Kang","year":"2013","unstructured":"Kang SH, et al. REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep. 2013;36(8):1147\u201352.","journal-title":"Sleep."},{"key":"1310_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.sleep.2017.07.021","volume":"40","author":"M Pujol","year":"2017","unstructured":"Pujol M, et al. Idiopathic REM sleep behavior disorder in the elderly Spanish community: a primary care center study with a two-stage design using video-polysomnography. Sleep Med. 2017;40:116\u201321.","journal-title":"Sleep Med."},{"key":"1310_CR10","doi-asserted-by":"publisher","unstructured":"Haba-Rubio J, et al. Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population. Sleep. 2018;41(2):zsx197. https:\/\/doi.org\/10.1093\/sleep\/zsx197.","DOI":"10.1093\/sleep\/zsx197"},{"key":"1310_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jns.2016.07.057","volume":"368","author":"SH Kang","year":"2016","unstructured":"Kang SH, et al. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson\u2019s disease. J Neurol Sci. 2016;368:374\u20138.","journal-title":"J Neurol Sci."},{"issue":"6","key":"1310_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/mds.24939","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, et al. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson\u2019s disease: a prospective study. Mov Disord. 2012;27(6):720\u20136.","journal-title":"Mov Disord."},{"issue":"6","key":"1310_CR13","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1007\/s00415-023-11659-5","volume":"270","author":"CE Cicero","year":"2023","unstructured":"Cicero CE, et al. Influence of RBD onset on the clinical characteristics of Parkinson\u2019s disease patients: a retrospective study. J Neurol. 2023;270(6):3171\u20138.","journal-title":"J Neurol."},{"issue":"8","key":"1310_CR14","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.3233\/JPD-223511","volume":"12","author":"L Pavelka","year":"2022","unstructured":"Pavelka L, et al. Body-first subtype of Parkinson\u2019s disease with probable REM-sleep behavior disorder is associated with non-motor dominant phenotype. J Parkinsons Dis. 2022;12(8):2561\u201373.","journal-title":"J Parkinsons Dis."},{"issue":"1","key":"1310_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cct.2013.06.002","volume":"36","author":"CG Moore","year":"2013","unstructured":"Moore CG, et al. Study in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humans. Contemp Clin Trials. 2013;36(1):90\u20138.","journal-title":"Contemp Clin Trials."},{"issue":"11","key":"1310_CR16","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.sleep.2014.06.002","volume":"15","author":"SJ McCarter","year":"2014","unstructured":"McCarter SJ, et al. Factors associated with injury in REM sleep behavior disorder. Sleep Med. 2014;15(11):1332\u20138.","journal-title":"Sleep Med."},{"issue":"5","key":"1310_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5664\/jcsm.6576","volume":"13","author":"RB Berry","year":"2017","unstructured":"Berry RB, et al. AASM scoring manual updates for 2017 (Version 2.4). J Clin Sleep Med. 2017;13(5):665\u20136.","journal-title":"J Clin Sleep Med."},{"issue":"6","key":"1310_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.5665\/sleep.1886","volume":"35","author":"B Frauscher","year":"2012","unstructured":"Frauscher B, et al. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep. 2012;35(6):835\u201347.","journal-title":"Sleep."},{"issue":"10","key":"1310_CR19","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.5665\/sleep.4076","volume":"37","author":"B Frauscher","year":"2014","unstructured":"Frauscher B, et al. Validation of an integrated software for the detection of rapid eye movement sleep behavior disorder. Sleep. 2014;37(10):1663\u201371.","journal-title":"Sleep."},{"issue":"9","key":"1310_CR20","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.sleep.2010.06.003","volume":"11","author":"R Ferri","year":"2010","unstructured":"Ferri R, et al. Improved computation of the atonia index in normal controls and patients with REM sleep behavior disorder. Sleep Med. 2010;11(9):947\u20139.","journal-title":"Sleep Med."},{"issue":"1","key":"1310_CR21","doi-asserted-by":"publisher","first-page":"20886","DOI":"10.1038\/s41598-022-25163-9","volume":"12","author":"A Rothenbacher","year":"2022","unstructured":"Rothenbacher A, et al. RBDtector: an open-source software to detect REM sleep without atonia according to visual scoring criteria. Sci Rep. 2022;12(1):20886.","journal-title":"Sci Rep."},{"issue":"1","key":"1310_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/mds.29249","volume":"38","author":"A Brink-Kjaer","year":"2023","unstructured":"Brink-Kjaer A, et al. Ambulatory detection of isolated rapid-eye-movement sleep behavior disorder combining actigraphy and questionnaire. Mov Disord. 2023;38(1):82\u201391.","journal-title":"Mov Disord."},{"issue":"11","key":"1310_CR23","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.5665\/sleep.3102","volume":"36","author":"RB Postuma","year":"2013","unstructured":"Postuma RB, et al. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep. 2013;36(11):1579\u201385.","journal-title":"Sleep."},{"issue":"4","key":"1310_CR24","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s10072-022-06513-x","volume":"44","author":"I Erkent","year":"2023","unstructured":"Erkent I, et al. Sleep disorders and polysomnography findings in patients with autoimmune encephalitis. Neurol Sci. 2023;44(4):1351\u201360.","journal-title":"Neurol Sci."},{"issue":"1","key":"1310_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.sleep.2007.11.019","volume":"10","author":"PT Teman","year":"2009","unstructured":"Teman PT, et al. Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset. Sleep Med. 2009;10(1):60\u20135.","journal-title":"Sleep Med."},{"key":"1310_CR26","doi-asserted-by":"publisher","unstructured":"Devine MF, et al. Objective sleep profile in LGI1\/CASPR2 autoimmunity. Sleep. 2022;45(2):zsab297. https:\/\/doi.org\/10.1093\/sleep\/zsab297.","DOI":"10.1093\/sleep\/zsab297"},{"issue":"6","key":"1310_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13(6):575\u201386.","journal-title":"Lancet Neurol."},{"issue":"6","key":"1310_CR28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/archneurol.2011.106","volume":"68","author":"JR Cornelius","year":"2011","unstructured":"Cornelius JR, et al. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol. 2011;68(6):733\u20138.","journal-title":"Arch Neurol."},{"issue":"12","key":"1310_CR29","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.sleep.2015.07.018","volume":"16","author":"SJ McCarter","year":"2015","unstructured":"McCarter SJ, et al. Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder. Sleep Med. 2015;16(12):1502\u201310.","journal-title":"Sleep Med."},{"issue":"10","key":"1310_CR30","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.5664\/jcsm.4120","volume":"10","author":"V Mysliwiec","year":"2014","unstructured":"Mysliwiec V, et al. Trauma associated sleep disorder: a proposed parasomnia encompassing disruptive nocturnal behaviors, nightmares, and REM without atonia in trauma survivors. J Clin Sleep Med. 2014;10(10):1143\u20138.","journal-title":"J Clin Sleep Med."},{"issue":"5","key":"1310_CR31","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ana.24385","volume":"77","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol. 2015;77(5):830\u20139.","journal-title":"Ann Neurol."},{"issue":"1","key":"1310_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41467-017-02761-0","volume":"9","author":"S Valencia Garcia","year":"2018","unstructured":"Valencia Garcia S, et al. Ventromedial medulla inhibitory neuron inactivation induces REM sleep without atonia and REM sleep behavior disorder. Nat Commun. 2018;9(1):504.","journal-title":"Nat Commun."},{"issue":"1","key":"1310_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-018-0016-5","volume":"4","author":"Y Dauvilliers","year":"2018","unstructured":"Dauvilliers Y, et al. REM sleep behaviour disorder. Nat Rev Dis Primers. 2018;4(1):19.","journal-title":"Nat Rev Dis Primers."},{"issue":"2","key":"1310_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.1967.47.2.117","volume":"47","author":"M Jouvet","year":"1967","unstructured":"Jouvet M. Neurophysiology of the states of sleep. Physiol Rev. 1967;47(2):117\u201377.","journal-title":"Physiol Rev."},{"issue":"4","key":"1310_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/bpa.12839","volume":"30","author":"S Koga","year":"2020","unstructured":"Koga S, et al. Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease. Brain Pathol. 2020;30(4):766\u201378.","journal-title":"Brain Pathol."},{"issue":"s2","key":"1310_CR36","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.3233\/JPD-191721","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer P, Van Den Berge N. Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis. J Parkinsons Dis. 2019;9(s2):S281\u201395.","journal-title":"J Parkinsons Dis."},{"issue":"1","key":"1310_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.28345","volume":"36","author":"A van der Heide","year":"2021","unstructured":"van der Heide A, et al. Stress and mindfulness in Parkinson\u2019s disease: clinical effects and potential underlying mechanisms. Mov Disord. 2021;36(1):64\u201370.","journal-title":"Mov Disord."},{"issue":"1","key":"1310_CR38","doi-asserted-by":"publisher","first-page":"e13966","DOI":"10.1111\/apha.13966","volume":"238","author":"D Kunz","year":"2023","unstructured":"Kunz D, et al. Sleep and circadian rhythms in alpha-synucleinopathies-perspectives for disease modification. Acta Physiol (Oxf). 2023;238(1):e13966.","journal-title":"Acta Physiol (Oxf)."},{"issue":"1","key":"1310_CR39","doi-asserted-by":"publisher","first-page":"7973","DOI":"10.1038\/s41598-022-11516-x","volume":"12","author":"C Gelegen","year":"2022","unstructured":"\u2022 Gelegen C, et al. Relevance of sleep and associated structural changes in GBA1 mouse to human rapid eye movement behavior disorder. Sci Rep. 2022;12(1):7973. GBA1- mouse model exhibits RBD and morphometric changes in the midbrain and pedunculopontine nucleus.","journal-title":"Sci Rep."},{"issue":"25","key":"1310_CR40","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1523\/JNEUROSCI.1828-22.2023","volume":"43","author":"K Kam","year":"2023","unstructured":"Kam K, et al. Effect of aging and a dual orexin receptor antagonist on sleep architecture and non-REM oscillations including an REM behavior disorder phenotype in the PS19 mouse model of tauopathy. J Neurosci. 2023;43(25):4738\u201349. https:\/\/doi.org\/10.1523\/JNEUROSCI.1828-22.2023.","journal-title":"J Neurosci."},{"issue":"3","key":"1310_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1056\/NEJM199701163360306","volume":"336","author":"A Brzezinski","year":"1997","unstructured":"Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336(3):186\u201395.","journal-title":"N Engl J Med."},{"issue":"3","key":"1310_CR42","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/1531-8257(199905)14:3<507::AID-MDS1021>3.0.CO;2-8","volume":"14","author":"D Kunz","year":"1999","unstructured":"Kunz D, Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord. 1999;14(3):507\u201311.","journal-title":"Mov Disord."},{"issue":"2","key":"1310_CR43","doi-asserted-by":"publisher","first-page":"e12759","DOI":"10.1111\/jpi.12759","volume":"71","author":"D Kunz","year":"2021","unstructured":"Kunz D, Stotz S, Bes F. Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic. J Pineal Res. 2021;71(2):e12759.","journal-title":"J Pineal Res."},{"issue":"4","key":"1310_CR44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2869.2010.00848.x","volume":"19","author":"D Kunz","year":"2010","unstructured":"Kunz D, Mahlberg R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res. 2010;19(4):591\u20136.","journal-title":"J Sleep Res."},{"issue":"4","key":"1310_CR45","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/acn3.753","volume":"6","author":"JS Jun","year":"2019","unstructured":"Jun JS, et al. Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder. Ann Clin Transl Neurol. 2019;6(4):716\u201322.","journal-title":"Ann Clin Transl Neurol."},{"issue":"2","key":"1310_CR46","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mds.27886","volume":"35","author":"M Gilat","year":"2020","unstructured":"Gilat M, et al. Melatonin for rapid eye movement sleep behavior disorder in Parkinson\u2019s disease: a randomised controlled trial. Mov Disord. 2020;35(2):344\u20139.","journal-title":"Mov Disord."},{"issue":"1","key":"1310_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11325-022-02572-8","volume":"27","author":"JI Byun","year":"2023","unstructured":"\u2022 Byun JI, et al. Comparative efficacy of prolonged-release melatonin versus clonazepam for isolated rapid eye movement sleep behavior disorder. Sleep Breath. 2023;27(1):309\u201318. Prospective open label RCT comparing clonazepam and melatonin in idiopathic RBD without meaningful difference between the two treatments.","journal-title":"Sleep Breath."},{"issue":"4","key":"1310_CR48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.5664\/jcsm.10426","volume":"19","author":"M Howell","year":"2023","unstructured":"Howell M, et al. Management of REM sleep behavior disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2023;19(4):769\u2013810.","journal-title":"J Clin Sleep Med."},{"issue":"4","key":"1310_CR49","doi-asserted-by":"publisher","first-page":"655","DOI":"10.5664\/jcsm.8308","volume":"16","author":"V Dokkedal-Silva","year":"2020","unstructured":"Dokkedal-Silva V, et al. Use of clonazepam in REM sleep behavior disorder: association with fall-related injuries and alternative treatments. J Clin Sleep Med. 2020;16(4):655\u20136.","journal-title":"J Clin Sleep Med."},{"key":"1310_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jns.2019.04.029","volume":"401","author":"C Shin","year":"2019","unstructured":"Shin C, et al. Clonazepam for probable REM sleep behavior disorder in Parkinson\u2019s disease: a randomized placebo-controlled trial. J Neurol Sci. 2019;401:81\u20136.","journal-title":"J Neurol Sci."},{"issue":"5","key":"1310_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.sleep.2013.01.007","volume":"14","author":"R Ferri","year":"2013","unstructured":"Ferri R, et al. Effects of long-term use of clonazepam on nonrapid eye movement sleep patterns in rapid eye movement sleep behavior disorder. Sleep Med. 2013;14(5):399\u2013406.","journal-title":"Sleep Med."},{"issue":"2","key":"1310_CR52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/0891988720915517","volume":"34","author":"HJ Lee","year":"2021","unstructured":"Lee HJ, Choi H, Yoon IY. Age of diagnosis and comorbid PLMD predict poor response of REM behavior disorder to clonazepam. J Geriatr Psychiatry Neurol. 2021;34(2):142\u20139.","journal-title":"J Geriatr Psychiatry Neurol."},{"issue":"4","key":"1310_CR53","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/mds.24909","volume":"27","author":"R Di Giacopo","year":"2012","unstructured":"Di Giacopo R, et al. Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson\u2019s disease. Mov Disord. 2012;27(4):559\u201361.","journal-title":"Mov Disord."},{"issue":"3","key":"1310_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/1567205011666140302195648","volume":"11","author":"V Brunetti","year":"2014","unstructured":"Brunetti V, et al. Rivastigmine for refractory REM behavior disorder in mild cognitive impairment. Curr Alzheimer Res. 2014;11(3):267\u201373.","journal-title":"Curr Alzheimer Res."},{"issue":"2","key":"1310_CR55","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5664\/jcsm.27771","volume":"6","author":"SB Yeh","year":"2010","unstructured":"Yeh SB, Yeh PY, Schenck CH. Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer\u2019s disease. J Clin Sleep Med. 2010;6(2):192\u20135.","journal-title":"J Clin Sleep Med."},{"key":"1310_CR56","doi-asserted-by":"publisher","first-page":"981249","DOI":"10.3389\/fneur.2022.981249","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, et al. Efficacy of idebenone in the treatment of iRBD into synucleinopathies (EITRS): rationale, design, and methodology of a randomized, double-blind, multi-center clinical study. Front Neurol. 2022;13:981249.","journal-title":"Front Neurol."},{"key":"1310_CR57","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.sleep.2021.02.038","volume":"81","author":"A Stefani","year":"2021","unstructured":"Stefani A, et al. Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: a double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson\u2019s disease dementia. Sleep Med. 2021;81:180\u20137.","journal-title":"Sleep Med."},{"key":"1310_CR58","doi-asserted-by":"publisher","unstructured":"During EH, et al. Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder. Sleep. 2023;46(8):zsad103. https:\/\/doi.org\/10.1093\/sleep\/zsad103.","DOI":"10.1093\/sleep\/zsad103"},{"issue":"11","key":"1310_CR59","doi-asserted-by":"publisher","first-page":"e11425","DOI":"10.1016\/j.heliyon.2022.e11425","volume":"8","author":"Z Que","year":"2022","unstructured":"Que Z, et al. The treatment efficacy of pharmacotherapies for rapid eye movement sleep behavior disorder with polysomnography evaluation: a systematic review and meta-analysis. Heliyon. 2022;8(11):e11425.","journal-title":"Heliyon."},{"issue":"5","key":"1310_CR60","doi-asserted-by":"publisher","first-page":"689","DOI":"10.5664\/jcsm.5796","volume":"12","author":"Y Esaki","year":"2016","unstructured":"Esaki Y, et al. An open-labeled trial of ramelteon in idiopathic rapid eye movement sleep behavior disorder. J Clin Sleep Med. 2016;12(5):689\u201393.","journal-title":"J Clin Sleep Med."},{"issue":"3","key":"1310_CR61","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2169\/internalmedicine.55.5464","volume":"55","author":"K Kashihara","year":"2016","unstructured":"Kashihara K, et al. Beneficial effects of ramelteon on rapid eye movement sleep behavior disorder associated with Parkinson\u2019s disease - results of a multicenter open trial. Intern Med. 2016;55(3):231\u20136.","journal-title":"Intern Med."},{"issue":"4","key":"1310_CR62","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/acn3.51738","volume":"10","author":"JE Elliott","year":"2023","unstructured":"Elliott JE, et al. Baseline characteristics of the North American prodromal Synucleinopathy cohort. Ann Clin Transl Neurol. 2023;10(4):520\u201335.","journal-title":"Ann Clin Transl Neurol."},{"issue":"7","key":"1310_CR63","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/mds.28577","volume":"36","author":"CMO de Almeida","year":"2021","unstructured":"de Almeida CMO, et al. Cannabidiol for rapid eye movement sleep behavior disorder. Mov Disord. 2021;36(7):1711\u20135.","journal-title":"Mov Disord."},{"key":"1310_CR64","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/NSS.S340949","volume":"14","author":"KJ Maddison","year":"2022","unstructured":"Maddison KJ, Kosky C, Walsh JH. Is there a place for medicinal cannabis in treating patients with sleep disorders? What we know so far. Nat Sci Sleep. 2022;14:957\u201368.","journal-title":"Nat Sci Sleep."},{"key":"1310_CR65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.sleep.2020.11.025","volume":"77","author":"F Cavalloni","year":"2021","unstructured":"Cavalloni F, et al. A case series and systematic review of rapid eye movement sleep behavior disorder outcome after deep brain stimulation in Parkinson\u2019s disease. Sleep Med. 2021;77:170\u20136.","journal-title":"Sleep Med."},{"issue":"2","key":"1310_CR66","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3171\/2022.12.JNS222251","volume":"139","author":"T Xue","year":"2023","unstructured":"Xue T, et al. Prefrontal association of subthalamic deep brain stimulation with rapid eye movement sleep behavior disorder in Parkinson\u2019s disease. J Neurosurg. 2023;139(2):451\u201362. https:\/\/doi.org\/10.3171\/2022.12.JNS222251.","journal-title":"J Neurosurg."},{"issue":"4","key":"1310_CR67","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.parkreldis.2010.01.001","volume":"16","author":"M Zibetti","year":"2010","unstructured":"Zibetti M, et al. Probable REM sleep behaviour disorder and STN-DBS outcome in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2010;16(4):265\u20139.","journal-title":"Parkinsonism Relat Disord."},{"key":"1310_CR68","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.parkreldis.2020.06.031","volume":"81","author":"S Park","year":"2020","unstructured":"Park S, et al. The probable REM sleep behavior disorder negatively affects health-related quality of life in Parkinson\u2019s disease with bilateral subthalamic nucleus stimulation. Parkinsonism Relat Disord. 2020;81:136\u20139.","journal-title":"Parkinsonism Relat Disord."},{"issue":"12","key":"1310_CR69","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30(12):1600\u201311.","journal-title":"Mov Disord."},{"issue":"12","key":"1310_CR70","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1007\/s10072-022-06374-4","volume":"43","author":"M Puligheddu","year":"2022","unstructured":"Puligheddu M, et al. Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study FARPRESTO. Neurol Sci. 2022;43(12):6919\u201328.","journal-title":"Neurol Sci."},{"key":"1310_CR71","doi-asserted-by":"publisher","first-page":"104859","DOI":"10.1016\/j.nbd.2020.104859","volume":"140","author":"AA Memon","year":"2020","unstructured":"Memon AA, Coleman JJ, Amara AW. Effects of exercise on sleep in neurodegenerative disease. Neurobiol Dis. 2020;140:104859.","journal-title":"Neurobiol Dis."},{"issue":"7 Suppl 1","key":"1310_CR72","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1212\/WNL.0000000000200235","volume":"99","author":"RB Postuma","year":"2022","unstructured":"\u2022 Postuma RB. Neuroprotective trials in REM sleep behavior disorder: the way forward becomes clearer. Neurology. 2022;99(7 Suppl 1):19\u201325. Review of potential for neuroprotective trials in RBD.","journal-title":"Neurology."},{"issue":"46","key":"1310_CR73","doi-asserted-by":"publisher","first-page":"11795","DOI":"10.1523\/JNEUROSCI.2546-16.2016","volume":"36","author":"M Hackius","year":"2016","unstructured":"Hackius M, et al. Electrophysiological evidence for alternative motor networks in REM sleep behavior disorder. J Neurosci. 2016;36(46):11795\u2013800.","journal-title":"J Neurosci."},{"issue":"1","key":"1310_CR74","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41531-022-00382-z","volume":"8","author":"AK Verma","year":"2022","unstructured":"Verma AK, et al. Basal ganglia engagement during REM sleep movements in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8(1):116.","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"1310_CR75","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41531-022-00292-0","volume":"8","author":"D Wasserman","year":"2022","unstructured":"Wasserman D, et al. Restricted truncal sagittal movements of rapid eye movement behaviour disorder. NPJ Parkinsons Dis. 2022;8(1):26.","journal-title":"NPJ Parkinsons Dis."},{"key":"1310_CR76","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.nbscr.2023.100094","volume":"14","author":"M Marano","year":"2023","unstructured":"Marano M, et al. Circadian profile, daytime activity, and the Parkinson\u2019s phenotype: a motion sensor pilot study with neurobiological underpinnings. Neurobiol Sleep Circadian Rhythms. 2023;14:100094.","journal-title":"Neurobiol Sleep Circadian Rhythms."},{"issue":"6465","key":"1310_CR77","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1126\/science.aax5440","volume":"366","author":"NE Fultz","year":"2019","unstructured":"Fultz NE, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science. 2019;366(6465):628\u201331.","journal-title":"Science."},{"key":"1310_CR78","doi-asserted-by":"publisher","first-page":"580853","DOI":"10.3389\/fnagi.2020.580853","volume":"12","author":"XL Si","year":"2020","unstructured":"Si XL, et al. Different perivascular space burdens in idiopathic rapid eye movement sleep behavior disorder and Parkinson\u2019s disease. Front Aging Neurosci. 2020;12:580853.","journal-title":"Front Aging Neurosci."},{"issue":"5","key":"1310_CR79","doi-asserted-by":"publisher","first-page":"e221848","DOI":"10.1148\/radiol.221848","volume":"307","author":"YJ Bae","year":"2023","unstructured":"Bae YJ, et al. Altered brain glymphatic flow at diffusion-tensor MRI in rapid eye movement sleep behavior disorder. Radiology. 2023;307(5):e221848.","journal-title":"Radiology."},{"key":"1310_CR80","doi-asserted-by":"crossref","unstructured":"\u2022 Kunz D, Stotz S, Bes F. Conversion to parkinsonism and dementia in REM-sleep behavior disorder using the chronobiotic melatonin. medRxiv. 2020:20224592. Prospective cohort study of melatonin vs other treatments in idiopathic RBD showed reduced phenoconversion to synucleinopathy in the melatonin group compared to the other group and compared to previously published rates of phenoconversion.","DOI":"10.1101\/2020.11.05.20224592"},{"key":"1310_CR81","doi-asserted-by":"publisher","unstructured":"Cardinali DP, Garay A. Melatonin as a chronobiotic\/cytoprotective agent in REM sleep behavior disorder. Brain Sci. 2023;13(5):797. https:\/\/doi.org\/10.3390\/brainsci13050797","DOI":"10.3390\/brainsci13050797"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01310-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-023-01310-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01310-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T08:42:32Z","timestamp":1700815352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-023-01310-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1007\/s11910-023-01310-1","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"27 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}